Abstract

Cord blood transplantation (CBT) provides a treatment scheme for hematologic diseases and leukemia in both children and adults. However, adverse reactions and transplantation-related death may still occur in patients receiving CBT even when donor and recipient have fully matched HLA in high-resolution HLA typing analysis. Single nucleotide polymorphisms (SNPs) of HLA-related and unrelated genes are known to associate with disease status of patients with unrelated stem cell transplantation. In this study, the genomic regions ranging from 500 base pairs upstream to 500 base pairs downstream of the eight SNPs that were reported as transplantation determinants by Petersdorf et al. were analyzed to evaluate whether genetic variants were associated with the survival status of patients, and the risk for severe (grades 3–4) graft-versus-host disease (GVHD) or cytomegalovirus (CMV) infection/reactivation. The analyses were performed in the mode of recipient genotype, donor genotype, and recipient-donor mismatching, respectively. By analysis of sixty-five patients and their HLA-matched unrelated donors, we found that five SNPs were associated with patient survival which included the recipient genotype with SNPs of rs107822 in the RING1 gene, and rs2070120, rs17220087 and rs17213693 in the HLA-DOB gene; and the recipient-donor mismatching with SNPs of rs9282369 in HLA-DOA gene, and rs2070120, rs17220087 and rs17213693 in the HLA-DOB gene. Five SNPs were associated with the risk for severe GVHD which included the donor genotype with SNPs of rs213210 and rs2523675; the recipient genotype with SNPs of rs9281491 in the HCP5 gene; and the recipient-donor mismatching with SNPs of rs209130 in the TRIM27 gene, and rs986522 in the COL11A2 gene. Six SNPs were related to the risk for CMV infection/reactivation which included the donor genotype with SNPs of rs435766, rs380924, and rs2523957; and the recipient-donor mismatching with SNPs of rs2070120, rs17220087, and rs17213693 in the HLA-DOB gene; and rs435766 and rs380924 in the MICD gene. This study provides the basis for larger analyses and if the results are confirmed, a way of selecting better unrelated CBT candidate donors.

Highlights

  • Cord blood transplantation (CBT) provides a treatment scheme for hematologic diseases and leukemia in both children and adults

  • Previous studies by Petersdorf et al revealed that the rs2242656 of BAG6, rs986522 of COL11A2, rs2244546 of HCP5, rs2523957 of MICD, rs429916 of human leukocyte antigen (HLA)-DOA, rs2071479 of HLA-DOB, rs107822 of RING1, and rs209130 of TRIM27 are related to the risk of relapse, survival rate, or graft-versus-host disease (GVHD) in patients receiving bone marrow stem cell t­ransplantation[8]

  • To analyze whether any Single nucleotide polymorphisms (SNPs) within the HLA region are associated with the occurrence of adverse reactions and the survival of patients, the genomic regions 500 bp upstream and downstream of the 8 sourced SNPs (Table 2) for the donor and recipient were amplified by PCR using the forward and reversed primers (Table 3)

Read more

Summary

Introduction

Cord blood transplantation (CBT) provides a treatment scheme for hematologic diseases and leukemia in both children and adults. Previous studies by Petersdorf et al revealed that the rs2242656 of BAG6, rs986522 of COL11A2, rs2244546 of HCP5, rs2523957 of MICD, rs429916 of HLA-DOA, rs2071479 of HLA-DOB, rs107822 of RING1, and rs209130 of TRIM27 are related to the risk of relapse, survival rate, or graft-versus-host disease (GVHD) in patients receiving bone marrow stem cell t­ransplantation[8]. Specific genotypes of these SNPs in the recipients, donors, or specific pairing of donor-recipient genotype are associated with the outcomes of transplantation.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.